Direct Oral Anticoagulant Offers Lower-Cost Alternatives

On December 23, 2019, the U.S. Food and Drug Administration approved two applications for the first generics of Eliquis (Apixaban) tablets. Eliquis helps reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. What is Eliquis?… Continue Reading…